B
BDTX
Black Diamond Therapeutics, Inc.
1.810
0.0000.00%After Hours: 1.760 -0.050 -2.76%19:34 07/16 EDT
OPEN/PREV CLOSE1.780/1.810
TODAY RANGE1.760-1.820
VOL855.86K
MARKET CAP103.72M
52 WEEK RANGE1.600-4.940
AVG VOL (3M)1.77M
% TURNOVER1.49%
TURNOVER--
P/E (TTM)-2.3879
% RANGE3.31%
EPS(TTM)-0.7580
P/E(FORWARD)-2.6232
P/B0.9944
BVPS1.820
DIVIDEND--
P/S1.477
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP102.58M
SHARES OUTSTANDING57.30M
NEXT EARNINGS08/05-08/10
FREE FLOAT56.67M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·07/06 05:51
Black Diamond Therapeutics: Positive Phase 2 Results Offer An Upside
Simply Wall St·07/01 10:43
Companies Like Black Diamond Therapeutics (NASDAQ:BDTX) Are In A Position To Invest In Growth
TipRanks·06/29 20:52
Black Diamond Shareholders Approve Directors and Annual Say-on-Pay
TipRanks·06/01 13:35
Wedbush Remains a Buy on Black Diamond Therapeutics (BDTX)
NASDAQ·05/27 15:16
BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst
NASDAQ·05/27 15:13
Black Diamond Stock Outlook After Q1 Beat and Cash Runway
NASDAQ·05/27 15:10
BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know
Benzinga·05/26 15:31
What's Going On With Black Diamond Therapeutics Stock Tuesday?
NASDAQ·05/25 14:53
BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data
Benzinga·05/22 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
TipRanks·05/22 00:20
Black Diamond Highlights Positive Phase 2 Silevertinib Lung Cancer Data
Same Industry
Name/Symbol
Change%
Price